Symetryx Corp - Sep 14, 2023 Form 4 Insider Report for NeuBase Therapeutics, Inc. (NBSE)

Role
10%+ Owner
Signature
Barry Shiff
Stock symbol
NBSE
Transactions as of
Sep 14, 2023
Transactions value $
-$375,620
Form type
4
Date filed
9/18/2023, 04:32 PM
Previous filing
Sep 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBSE Common Stock, Par Value $0.0001 per Share Sale -$186K -129K -45.71% $1.44 153K Sep 14, 2023 Direct
transaction NBSE Common Stock, Par Value $0.0001 per Share Sale -$130K -103K -67.39% $1.26 50K Sep 15, 2023 Direct
transaction NBSE Common Stock, Par Value $0.0001 per Share Sale -$59.5K -50K -100% $1.19 0 Sep 18, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

As of September 18, 2023, Symetryx Corporation does not own any shares of Common Stock of NeuBase Therapeutics, Inc.